Mechanism of the cytotoxicity of Asterriquinone, a metabolite of Aspergillus terreus

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3675-3679

  Kaji, Akira ^a   Saito, Ryo ^a   Nomura, Masaaki ^b   Miyamoto, Ken Ichi ^b   Kiriyama, Noriki ^a  

^a HOKURIKU UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Asterriquinone; Cell cycle; Cytotoxicity; DNA intercalation

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; DOXORUBICIN; QUINONE DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASPERGILLUS TERREUS; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DNA CROSS LINKING; DNA DEGRADATION; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; LEUKEMIA P 388; METHYLATION; MITOSIS; MOUSE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; ASPERGILLUS; CELL CYCLE; CROSS-LINKING REAGENTS; CYTOTOXINS; DNA FRAGMENTATION; DNA, NEOPLASM; INDOLES; MICE; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0030775174     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Yamamoto Y, Kiriyama N, Shimizu S, and Koshimura S: Antitumor activity of asterriquinone, a metabolic product from Aspergillus terreus. Jpn J Cancer Res (Gann) 67: 623-624, 1976.
2. Shimizu S, Yamamoto Y, and Koshimura S: Antitumor activity of asterriquinones from Aspergillus fungi. IV. An attempt to modify the structure of asterriquinones to increase the activity. Chem Pharm Bull 30: 1896-1899, 1982.
3. Shimizu S, Yamamoto Y, Inagaki J, and Koshimura S: Antitumor effect and structure-activity relationship of asterriquinone analogs. Jpn J Cancer Res (Gann) 73: 642-648, 1982.
4. Yamamoto Y, Nishimura K, and Kiriyama N: Studies on the metabolic products of Aspergillus terreus. I. Metabolites of the strain IFO 6123. Chem Pharm Bull 24: 1853-1859, 1976.
5. Carmichael J, DeGraff WG, Gazdar AF. Minna JD, and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
6. Sriram R and Ali-Osman F: S 1-nuclease enhancement of the ethidium bromide binding assay of drug-induced DNA interstrand crosslinking in human brain tumor cells. Anal Biochem 187: 345-348, 1990.
7. Telford WG, King LE, and Fraker PJ: Rapid quantitation in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods 172: 1-16, 1994.
8. Calabresi P and Chabner BA: Chemotherapy of neoplastic diseases. In: Pharmacologic Basis of Therapeutics, Gilman AG, Rall TW, Nies AS, Taylor P, eds. Pergamon Press. New york, pp. 1202-1263, 1990.
9. Meijer C, Mulder NH, Timmer-Bosscha H, Zijlatra JG, and De Vries EGE: Role of free radicals in an Adriamycin-resistant human small-cell lung-cancer cell line. Cancer Res 47: 4613-4617, 1987.
10. Bell DF, Bell RS, Mankin HJ, Gehnhardt MC, Weltie F, and O'Brien T: Kinetic effects of adriamycin and bleomycin on two osteosarcoma models. J Orthp Res 6: 51-57, 1988.
11. Aller P, Rius C, Mata F, Zorrilla A, Cabanas C, Bellon T, and Bernabeu C: Camptothecin induces differentiation and stimulates the expression of diffierentiation-related genes in U937 human promyelocytic leukemia cells. Cancer Res 52: 1245-1251, 1992.
12. Ling YH, Priebe W, and Perez-Soler R: Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res 53: 1845-1852, 1993.
13. Solary E, Bertrand R, Kohn KW, and Prommier Y: Differentiation induction of apoptosis in undifferentiated and differentiated HL-60 cells by topoisomerase I and II inhibitors. Blood 81: 1359-1368, 1993.
14. Piacentini M, Fesus L, and Melino G: Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells. FEBS Lett 320: 150-154, 1993.
15. Garcia I, Martinou I, Tsujimoto Y, and Martinou JC: Prevention of programmed cell death of sympathetic neurons by the bcl-2 protoncogene. Science 258: 302-304, 1992.
16. Gavrieli Y, Sherman Y, and Ben-Sasson SA: Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 119: 493-498, 1992.
17. Karammer PH, Behrmann I, Daniel P, Dehin J, and Debatin KM: Regulation of apoptosis in the immune system. Curr Opin Immunol 6: 279-289, 1994.